loadpatents
Patent applications and USPTO patent grants for Ruggeri; Roger B..The latest application filed is for "glp-1 receptor agonists and uses thereof".
Patent | Date |
---|---|
GLP-1 Receptor Agonists and Uses Thereof App 20210332034 - Aspnes; Gary Erik ;   et al. | 2021-10-28 |
GLP-1 Receptor Agonists and Uses Thereof App 20210163455 - Aspnes; Gary Erik ;   et al. | 2021-06-03 |
GLP-1 receptor agonists and uses thereof Grant 10,934,279 - Aspnes , et al. March 2, 2 | 2021-03-02 |
Glp-1 Receptor Agonists And Uses Thereof App 20210047298 - Aspnes; Gary Erik ;   et al. | 2021-02-18 |
GLP-1 receptor agonists and uses thereof Grant 10,851,081 - Aspnes , et al. December 1, 2 | 2020-12-01 |
Glp-1 Receptor Agonists And Uses Thereof App 20200255406 - Kind Code | 2020-08-13 |
GLP-1 receptor agonists and uses thereof Grant 10,683,281 - Aspnes , et al. | 2020-06-16 |
GLP-1 receptor agonists and uses thereof Grant 10,676,465 - Aspnes , et al. | 2020-06-09 |
GLP-1 receptor agonists and uses thereof Grant 10,669,259 - Aspnes , et al. | 2020-06-02 |
GLP-1 Receptor Agonists and Uses Thereof App 20190382387 - Aspnes; Gary Erik ;   et al. | 2019-12-19 |
GLP-1 Receptor Agonists and Uses Thereof App 20190382384 - Aspnes; Gary Erik ;   et al. | 2019-12-19 |
GLP-1 Receptor Agonists and Uses Thereof App 20190382388 - Aspnes; Gary Erik ;   et al. | 2019-12-19 |
GLP-1 Receptor Agonists and Uses Thereof App 20190119255 - Aspnes; Gary Erik ;   et al. | 2019-04-25 |
GLP-1 receptor agonists and uses thereof Grant 10,208,019 - Aspnes , et al. Feb | 2019-02-19 |
GLP-1 Agonists and Uses Thereof App 20180170908 - Aspnes; Gary Erik ;   et al. | 2018-06-21 |
2-thiopyrimidinones Grant 9,873,673 - Carpino , et al. January 23, 2 | 2018-01-23 |
2-Thiopyrimidinones App 20160304469 - Carpino; Philip A. ;   et al. | 2016-10-20 |
2-thiopyrimidinones Grant 9,399,626 - Carpino , et al. July 26, 2 | 2016-07-26 |
2-Thiopyrimidinones App 20140288049 - Carpino; Philip A. ;   et al. | 2014-09-25 |
2-Thiopyrimidinones Grant 8,841,314 - Hepworth , et al. September 23, 2 | 2014-09-23 |
2-thiopyrimidinones Grant 8,835,449 - Conn , et al. September 16, 2 | 2014-09-16 |
2-Thiopyrimidinones App 20130296351 - Carpino; Philip A. ;   et al. | 2013-11-07 |
2-Thiopyrimidinones App 20130123230 - Carpino; Philip A. ;   et al. | 2013-05-16 |
Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors Grant 8,389,011 - Crew , et al. March 5, 2 | 2013-03-05 |
Pharmaceutical Compositions Of Cholesteryl Ester Transfer Protein Inhibitors App 20120277315 - Crew; Marshall D. ;   et al. | 2012-11-01 |
Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors Grant 8,197,848 - Crew , et al. June 12, 2 | 2012-06-12 |
Pharmaceutical compositions of cholesteryl ester transfer protein inhibitor Grant 8,048,452 - Curatolo , et al. November 1, 2 | 2011-11-01 |
Diaryl ether derivatives and uses thereof Grant 7,618,996 - Ruggeri , et al. November 17, 2 | 2009-11-17 |
Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof Grant 7,615,651 - Ruggeri , et al. November 10, 2 | 2009-11-10 |
Diaryl, Dipyridinyl and Aryl-Pyridinyl Derivatives and Uses Thereof App 20080167371 - Ruggeri; Roger B. ;   et al. | 2008-07-10 |
Diaryl Ether Derivatives and Uses Thereof App 20080070887 - Ruggeri; Roger B. ;   et al. | 2008-03-20 |
Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors App 20070282009 - Crew; Marshall D. ;   et al. | 2007-12-06 |
Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors Grant 7,235,259 - Crew , et al. June 26, 2 | 2007-06-26 |
4-Amino Substituted-2-Substituted-1,2,3,4-tetrahydroquinoline Compounds App 20060247272 - Ruggeri; Roger B. ;   et al. | 2006-11-02 |
Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors Grant 7,115,279 - Curatolo , et al. October 3, 2 | 2006-10-03 |
Pharmaceutical Compositions of Cholesteryl Ester Transfer Protein Inhibitor App 20060211654 - Curatolo; William J. ;   et al. | 2006-09-21 |
CETP inhibitors in combination with antihypertensive agents and uses thereof Grant 7,071,210 - Ruggeri July 4, 2 | 2006-07-04 |
CETP inhibitors in combination with antihypertensive agents and uses thereof App 20060128751 - Ruggeri; Roger B. | 2006-06-15 |
Quinoline and quinoxaline compounds App 20060122224 - Bechle; Bruce M. ;   et al. | 2006-06-08 |
4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds App 20060063803 - Ruggeri; Roger B. ;   et al. | 2006-03-23 |
N-[(substituted five-membered di-or triaza diunsaturated ring) carbonyl] guanidine derivatives for the treatment of ischemia Grant 6,974,813 - Hamanaka , et al. December 13, 2 | 2005-12-13 |
4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines App 20050245570 - DeNinno, Michael P. ;   et al. | 2005-11-03 |
4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines Grant 6,906,082 - DeNinno , et al. June 14, 2 | 2005-06-14 |
Quinoline and quinoxaline compounds App 20040204450 - Bechle, Bruce M. ;   et al. | 2004-10-14 |
Microsomal triglyceride transfer protein inhibitor App 20040132745 - Bertinato, Peter ;   et al. | 2004-07-08 |
4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines App 20040092550 - DeNinno, Michael P. ;   et al. | 2004-05-13 |
Methods of treatment with CETP inhibitors and antihypertensive agents App 20040053842 - Nguyen, Tu Trung ;   et al. | 2004-03-18 |
CETP inhibitors in combination with antihypertensive agents and uses thereof App 20040039018 - Ruggeri, Roger B. | 2004-02-26 |
Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors App 20030186952 - Crew, Marshall D. ;   et al. | 2003-10-02 |
N-[(substituted five-membered di-or triaza diunsaturated ring)carbonyl] guanidine derivatives for the treatment of ischemia App 20030149043 - Hamanaka, Ernest S. ;   et al. | 2003-08-07 |
4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines Grant 6,586,448 - DeNinno , et al. July 1, 2 | 2003-07-01 |
N-[(substituted five-membered di- or triaza diunsaturated ring)carbonyl] guanidine derivatives for the treatment of ischemia Grant 6,492,401 - Hamanaka , et al. December 10, 2 | 2002-12-10 |
4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines Grant 6,489,478 - DeNinno , et al. December 3, 2 | 2002-12-03 |
Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors App 20020103225 - Curatolo, William J. ;   et al. | 2002-08-01 |
4-carboxyamino-2-methyl-1,2,3,4,-tetrahydroquinolines Grant 6,395,751 - DeNinno , et al. May 28, 2 | 2002-05-28 |
Oxy substituted 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines Grant 6,362,198 - Goldstein , et al. March 26, 2 | 2002-03-26 |
Annulated 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines Grant 6,310,075 - DeNinno , et al. October 30, 2 | 2001-10-30 |
4-Carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines Grant 6,197,786 - DeNinno , et al. March 6, 2 | 2001-03-06 |
4-carboxyamino-2-methyl-1,2,3,4,-tetrahydroquinolines Grant 6,147,090 - DeNinno , et al. November 14, 2 | 2000-11-14 |
Annulated 4-carboxyamino-2-methyl-1,2,3,4,-tetrahydroquinolines Grant 6,147,089 - DeNinno , et al. November 14, 2 | 2000-11-14 |
4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines Grant 6,140,343 - DeNinno , et al. October 31, 2 | 2000-10-31 |
Oxy substituted 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines Grant 6,140,342 - Goldstein , et al. October 31, 2 | 2000-10-31 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.